Cargando…
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
Autores principales: | Mair, Maximilian J., Mitterer, Manfred, Gattinger, Pia, Berger, Julia M., Trutschnig, Wolfgang, Bathke, Arne C., Gansterer, Margaretha, Berghoff, Anna S., Laengle, Severin, Gottmann, Lynn, Buratti, Thomas, Haslacher, Helmuth, Lamm, Wolfgang W., Raderer, Markus, Tobudic, Selma, Fuereder, Thorsten, Valenta, Rudolf, Fong, Dominic, Preusser, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001251/ https://www.ncbi.nlm.nih.gov/pubmed/35429443 http://dx.doi.org/10.1016/j.ccell.2022.04.003 |
Ejemplares similares
-
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022) -
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic: Conclusions for crisis response at a high-volume oncology center
por: Berger, Julia M., et al.
Publicado: (2021) -
1692P SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria
por: Berghoff, A.S., et al.
Publicado: (2020) -
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
por: Fuereder, Thorsten, et al.
Publicado: (2020) -
Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort
por: Mair, M.J., et al.
Publicado: (2023)